EIB to provide venture debt funding of up to €10 million
The European Investment Bank (EIB) has taken a further step forward in backing the Spanish and European biomedical sector. To this end,...
Initial Clinical experience with the ANA at VdH.pdf by A. Tomasello
Fig. 1. Thrombectomy setting with devices deployed. ANA funnel was deployed and could be visualized either at extra cranial (A) or intr...
Suction force rather than aspiration flow correlates with recanalization in hard clots
ANA Advanced Neurovascular Access provides a novel funnel component designed to reduce clot fragmentation and facilitate retrieval in c...
Anaconda Biomed is awarded with “IGNASI PUJOL AWARD 2020” by DIARI ARA.
Anaconda has been recognised for the promoting of entrepreneurship in the Catalonian start up ecosystem boom since its foundation.Pres...
Anaconda Biomed is awarded with INICIA by EL PERIODICO DE CATALUÑA
The prize is included in the "BEST COMPANY OF THE YEAR" ceremony organized by the newspaper EL PERIODICO DE CATALUÑA.
Anaconda has bee...
ANACONDA BIOMED – a whole clot approach to stroke thrombectomy
ANACONDA BIOMED - MedTech Strategist article by Mary Thomson
See PDF
Evaluating the preclinical efficacy and safety of the ANCD in a swine clot model
Abstract
Background The Advanced Thrombectomy System (ANCD) provides a new funnel component designed to reduce clot fragmentation an...
Anaconda Biomed S.L. Secures €20 Million Round of Funding
(PICTURE: from left to right) Sylvain Sachot, Investment Director at ASABYS Partners; François Salmon, CEO of Anaconda Biomed S.L, Jose...
Anaconda Biomed Announces First-in-Human Study of Next-Generation Thrombectomy System
Anaconda Biomed, a medical technology company developing a next-generation thrombectomy system for the treatment of ischemic s...
NEW GRANT: NUCLIS ACCIÓ – GENERALITAT DE CATALUNYA
ANACONDA BIOMED gets a grant from ACCIÓ, the Agency for Business Competitiviness of la Generalitat de Catalunya. With this new s...